Jo Milner
Impact in
- Geriatrics and Gerontology top 0.5%
- Sirtuins and Resveratrol in Medicine
- Oncology top 1%
- Cancer-related Molecular Pathways
Papers in
-
- Epigenetics and DNA Methylation 7
- DNA Repair Mechanisms 6
- RNA Interference and Gene Delivery 6
- RNA modifications and cancer 6
- Oncology 31
- Cancer-related Molecular Pathways 28
- Co-authors
- Ming Jiang (8 shared papers)Elizabeth Medcalf (2 shared papers)Jack R. Ford (4 shared papers)Andrei L. Okorokov (8 shared papers)Carlos P. Rubbi (7 shared papers)Simon J. Allison (7 shared papers)John R. P. Knight (4 shared papers)A Cook (3 shared papers)
- Journals
- Oncogene (11 papers)Virology (5 papers)Molecular and Cellular Biology (4 papers)The EMBO Journal (3 papers)Nature (3 papers)
- Partner nations
- United KingdomUnited StatesCanada
In The Last Decade
Jo Milner
58 papers receiving 3.6k citations
Jo Milner's Hit Papers
Peers
Comparison fields: 5 of 108
- Geriatrics and Gerontology 411
- Oncology 1.6k
- Biotechnology 439
- Molecular Biology 2.4k
- Cancer Research 476
Countries citing papers authored by Jo Milner
This map shows the geographic impact of Jo Milner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jo Milner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jo Milner more than expected).
Fields of papers citing papers by Jo Milner
This network shows the impact of papers produced by Jo Milner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jo Milner. The network helps show where Jo Milner may publish in the future.
Co-authors
The 25 scholars most cited alongside Jo Milner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 58 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation Hit paper breakdown → | 1991 | 529 |
| 2 | 2002 | 305 | |
| 3 | 2005 | 247 | |
| 4 | 2005 | 230 | |
| 5 | 1981 | 166 | |
| 6 | 1997 | 139 | |
| 7 | 2003 | 128 | |
| 8 | 1984 | 117 | |
| 9 | 2003 | 112 | |
| 10 | 2008 | 106 | |
| 11 | 2006 | 99 | |
| 12 | 2011 | 84 | |
| 13 | Modulation by copper of p53 conformation and sequence-specific DNA binding: role for Cu(II)/Cu(I) redox mechanism. | 1995 | 76 |
| 14 | 1991 | 68 | |
| 15 | 2000 | 68 | |
| 16 | 1991 | 62 | |
| 17 | 1997 | 57 | |
| 18 | 1995 | 56 | |
| 19 | 1998 | 56 | |
| 20 | 2002 | 55 |
About Jo Milner
Jo Milner is a scholar working on Molecular Biology, Oncology, Genetics, Biotechnology and Geriatrics and Gerontology, having authored 58 papers that have together received 3.7k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (28 papers), Cancer Research and Treatments (11 papers), Virus-based gene therapy research (11 papers), Sirtuins and Resveratrol in Medicine (8 papers), Epigenetics and DNA Methylation (7 papers), DNA Repair Mechanisms (6 papers), RNA Interference and Gene Delivery (6 papers) and RNA modifications and cancer (6 papers). The work is most often cited by research in Geriatrics and Gerontology (411 citations), Oncology (1.6k citations), Biotechnology (439 citations), Molecular Biology (2.4k citations) and Cancer Research (476 citations). Jo Milner has collaborated with scholars based in United Kingdom, United States and Canada. Frequent co-authors include Ming Jiang, Elizabeth Medcalf, Jack R. Ford, Andrei L. Okorokov, Carlos P. Rubbi, Simon J. Allison, John R. P. Knight, A Cook, Shafiq U. Ahmed and Nik Veldhoen. Their work appears in journals such as Oncogene, Virology, Molecular and Cellular Biology, The EMBO Journal and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.